Global Gynecological Device Tools Market - 2022-2029

Global Gynecological Device Tools Market - 2022-2029

Market Overview

The global gynecological device tools market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 11.2% during the forecast period (2022-2029).

Gynecology devices used by gynecologists and obstetricians provide treatment of the female’s reproductive system. These instruments manage the female’s reproductive system, pregnancy and childbirth. It is used for loop electrical excision procedure (LEEP), colposcopy, endometrial biopsy, dilation and curettage (D&C), IUD insertion, tubal ligation and ovarian cystectomy.

Market Dynamics

The gynecological device tools market growth is driven by the rising incidence of gynecological disease related to the female reproductive system, rising adoption of gynecological devices for the diagnosis and treatment of diseases, technological advancement, and research and development activities.

The increasing awareness in women regarding cancer care is expected to drive the market growth

The rising prevalence of different types of cancer, vulvar cancer, vaginal cancer and others, is expected to boost the market over the forecast period. According to the World Congress on Gynecology and Obstetrics (WCGO) 2022 data, oncologists are specialists with immense knowledge and training to diagnose and treat different types of cancers, such as uterine, vulvar, vaginal cancer, ovarian cancer and cervical cancer. They serve as a leader in woman’s Gynecologic cancer care. It is important to seek advice from a Gynecologic oncologist before starting the treatment so that proper care and therapy will be delivered based on the cancer stage. The European Society of Gynecologic Oncology and the society of Gynecologic oncology are the Gynecologic oncologist professional organization. For Gynecologic oncologists and other medical professionals who take part in treating Gynecologic cancers. The gynecologic oncology group is a professional organization. In September (Every year), Gynecologic and ovarian cancer awareness is declared to instruct women about the symptoms and signs of early diagnosis.

In addition, the market players are applying market strategies, including product launches and collaboration, to expand their business. For instance, in October 2021, Hologic, Inc. agreed to acquire Bolder Surgical, a U.S.-based surgical devices company. The acquisition will contain laparoscopic dissecting, diving, and vessel sealing devices, including Bolder’s CoolSeal, the JustRight 5 mm stapler, and JustRight 3 mm vessel sealer. Also, in January 2022, The Women’s Hospital at Jackson Memorial, HCA Florida Healthcare’s Kendall Regional Medical Center, and AdventHealth Celebration started using the Hominis Surgical System, robotic surgical technology by Memic Innovative Surgery for gynecological procedures.

The adverse effects of gynecological device tools will hamper the growth of the market

However, energy-based devices for gynecological use, such as in the treatment of vaginal rejuvenation, show symptoms related to urinary incontinence, menopause, or sexual function and can cause serious adverse events. The adverse effects include scarring, vaginal burns, pain during sex, and recurring pain. These factors are limiting the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global gynecological device tools market. As per the article published in Internet Interventions in December 2021, to the transformations in the acute treatment of COVID-19 disease, numerous other changes have happened in day-to-day medical care since then. Intentional operations have been delayed, and investigations and therapies have also been postponed. Due to pandemic containment measures, many patient appointments had to be canceled or switched to digital health. However, the clinical care of the patients had to be continued. New concepts and ideas were used. The topic of Digitization was driven forward by the COVID-19 pandemic.

In 2022, the situation is recovering from COVID-19 the almost every patient can access healthcare facilities and take regular treatment. The rising gynecological surgery and increasing awareness of care of reproductive health drive the market worldwide.

Segment Analysis

The Endometrial Ablation Devices segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The endometrial ablation devices segment is anticipated to boost the market over the forecast period. As per the United States FDA October 2021, Endometrial ablation is a minimally invasive surgical procedure utilized to treat heavy menstrual bleeding (periods). Heavy menstrual bleeding is a typical issue. Nearly one out of three patients who get their period seek therapy for heavy menstrual bleeding. The FDA has approved endometrial ablation devices for premenopausal patients with heavy menstrual bleeding due to benign (non-cancerous) reasons for whom childbearing is complete. The major potential benefit of the procedure is the reduction in menstrual bleeding and headway in quality of life.

In addition, the Hologic offers an endometrial ablation device. Navasure provides women comfort, confidence and quality of life. It helps to reduce or stop abnormal uterine bleeding. Furthermore, in February 2021, Cooper Surgical acquired the California-based AEGEA Medical and its FDA-approved Mara Water Vapor Ablation System. The acquisition makes on over 30 years of experience in women’s healthcare and complements CooperSurgical’s expanding portfolio of medical products focused on clinic and practice-based women’s health.

Geographical Analysis

North America region holds the largest market share of the global gynecological device tools market

North America dominates the market for gynecological device tools and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to increasing demand for gynecological surgeries, awareness of reproductive disorders and treatments, advanced healthcare infrastructure, and technological advancement in gynecological devices. As per the article published in New Medical Devices in April 2020, the United States is a large market for medical devices worldwide. Accessing and adopting the new medical device for obstetric and gynecological care. Moreover, the USFDA takes initiatives to raise awareness of these devices in the region.

In addition, the market players are adopting the market strategies such as product launches and collaboration. For instance, in September 2020, GE Healthcare launched Voluson SWIFT, an AI-enhanced women’s health ultrasound with industry-first auto-recognition tools to assist efficiency. Voluson SWIFT offers the ultrasound experience for women’s health healthcare professionals by incorporating intelligent components that can lessen patient scanning time by as much as 45% and automate exam measurements resulting in considerable time savings for patients. Also, in September 2021, Ethicon introduced the industry’s first powered circular stapler for colorectal, gynecological, gastric, and thoracic surgery. It allows the address of serious intricacies associated with colorectal and gastric surgery. The Echelon Circular Powered Stapler decreases leaks by 61% at the staple line, compared to Medtronic’s DST Series EEA Stapler.

Competitive Landscape

The gynecological device tools market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Boston Scientific Corporation, Ethicon, Inc., Karl Storz Gmbh & Co. KG, Cooper Surgical, Inc., Hologic, Inc., Medtronic plc, Olympus Corporation, Stryker Corporation, Richard Wolf GmbH, and MedGyn Product Inc. among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, which are contributing to the growth of the gynecological device tools market globally.

For instance,

In March 2022, Endoluxe, a California-based company, introduced Endoluxe eVS, HD wireless endoscopic camera equipped with TowerTech for gynecological, urological, ENT, orthopedics, and general surgery.

Boston Scientific Corporation

Overview:

Boston Scientific Corporation is a medical device and biotechnological company founded in 1979 and headquartered in the United States. It partnered with GYN surgeons to continually innovate and advance the quality of patient care with effective solutions.

Product Portfolio:

AcuPulse DUO CO2 Laser System: It combines of fiber and free-beam energy delivery on a single device. The system is available in 30W/40W models, with or without the SurgiTouch Scanner.

The global gynecological device tools market report would provide access to approximately 45+ market data tables, 50+ figures, and in the range of 200+ (approximate) pages.